Benzinga's Top Downgrades
June 29, 2015 at 10:01 AM EDT
Analysts at Leerink Swann downgraded Kythera Biopharmaceuticals Inc (NASDAQ: KYTH) from Outperform to Market Perform. Kythera ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.